Investing.com UK - Financial Markets Worldwide
NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

General Dynamics Likely To Report Lower Q3 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

Published 25/10/2023, 08:38
© Reuters. General Dynamics Likely To Report Lower Q3 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts
GD
-

Benzinga - by Lisa Levin, Benzinga Editor.

General Dynamics Corporation (NYSE: GD) is expected to release financial results for its first quarter, before the opening bell on Oct. 25, 2023.

Analysts expect the company to post quarterly earnings at $2.75 per share, down from year-ago earnings of $3.26 per share. The company’s revenue might come in at $9.48 billion, compared to $9.92 billion in the year-ago period.

General Dynamics recently won a $967 million contract modification from the U.S. Navy for Lead Yard Support and Development and Design efforts for Virginia-class submarines.

General Dynamics shares fell 0.1% to close at $233.00 on Tuesday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.

  • Susquehanna analyst Charles Minervino reiterated a Positive rating with a price target of $270 on Sept. 25, 2023. This analyst has an accuracy rate of 70%.
  • Citigroup analyst Jason Gursky maintained a Buy rating with a price target of $283 on Sept. 19, 2023. This analyst has an accuracy rate of 68%.
  • Wells Fargo analyst Sarah Akers maintained an Overweight rating and cut the price target from $258 to $243 on Sept. 18, 2023. This analyst has an accuracy rate of 69%.
  • JP Morgan analyst Seth Seifman maintained an Overweight rating and boosted the price target from $245 to $251 on July 27, 2023. This analyst has an accuracy rate of 80%.
  • Morgan Stanley analyst Kristine Liwag maintained an Equal-Weight rating and increased the price target from $248 to $250 on July 27, 2023. This analyst has an accuracy rate of 62%.
Read This Next: 'Never Buy A Drug Stock Just For The Yield': Jim Cramer On This Big Pharma Company

Latest Ratings for GD

DateFirmActionFromTo
Mar 2022Wells FargoMaintainsOverweight
Mar 2022Morgan StanleyMaintainsEqual-Weight
Feb 2022Morgan StanleyUpgradesUnderweightEqual-Weight
View More Analyst Ratings for GD

View the Latest Analyst Ratings

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.